Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.
Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA Locations section listing all site locations by state has been added, and the HHS Vulnerability Disclosure notice and per-state location blocks have been removed.SummaryDifference2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2, with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check36 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1; no study details, eligibility criteria, or outcomes appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check43 days agoChange DetectedRemoval of the government funding notice at the top of the page; all study details and navigational elements remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check58 days agoChange DetectedNo additions or deletions were observed on the Study Details page for NCT03002077; the content remains the same.SummaryDifference0.2%
- Check86 days agoChange DetectedUpdate adds an operational status notice and a new software version (v3.2.0), replacing the old v3.0.2.SummaryDifference3%
Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.